[{"status": "Terminated", "city": "Basel", "state": "N/A", "country": "Switzerland", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63656", "recalling_firm": "F. Hoffmann-LaRoche Ltd.", "address_1": "Grenzacherstrasse 124", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "No product distributed in the USA.  Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.", "recall_number": "D-105-2013", "product_description": "Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom", "product_quantity": "42010 vials", "reason_for_recall": "Lack of Assurance of Sterility; container closure issues with the bulk batch.", "recall_initiation_date": "20120905", "center_classification_date": "20121221", "termination_date": "20130829", "report_date": "20130102", "code_info": "bulk lot N0019, Expiration Date: 11 2014  Warennummer: 10131968  Chargennummer:NXXXX 2000609D  Finished product Lot N0019B01-N0019B12"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BN200952"], "brand_name": ["HEXTEND"], "generic_name": ["HETASTARCH"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HETASTARCH"], "rxcui": ["310757", "404665"], "spl_id": ["e72c78a5-62ca-42c8-ace7-d70be50aad36"], "spl_set_id": ["fc79700c-6c3b-4998-8307-4dc8c81c5041"], "package_ndc": ["0409-1555-64", "0409-1555-54"], "is_original_packager": [true], "nui": ["N0000184175", "N0000009361", "N0000010288", "M0020435"], "pharm_class_epc": ["Plasma Volume Expander [EPC]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_cs": ["Starch [CS]"], "unii": ["875Y4127EA"]}, "product_type": "Drugs", "event_id": "63522", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-184-2013", "product_description": "HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045,  NDC 0409-1555-54", "product_quantity": "11,412 bags", "reason_for_recall": "Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.", "recall_initiation_date": "20121022", "center_classification_date": "20130305", "termination_date": "20150331", "report_date": "20130313", "code_info": "Lot # 10-199-JT Exp. 10/13"}, {"country": "United States", "city": "Lynwood", "address_1": "11865 Alameda St", "reason_for_recall": "Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.  If the product is shaken or warmed the white particles goes into the solution.", "address_2": "11840 S Alameda ST", "product_quantity": "35,652 bottles (2,971 cases)", "code_info": "Lot# 68089, 68415, 70046, 700516, 70665, 71157, 71704, 80795;  FP-38-081-57313; FP-38-041-57307", "center_classification_date": "20130307", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Rite Aid Maximum Strength Tussin Cough & Cold Mucus Relief CF, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg, 4 FL. OZ./12 PK (UPC Code: 0-11822-57307-8) and 8 FL.OZ./12 PK (UPC Code: 0-11822-57313-9),  Distributed by: Rite Aid, Camp Hill, PA, 17011", "report_date": "20130313", "classification": "Class III", "openfda": {}, "recalling_firm": "Aaron Industries Inc", "recall_number": "D-186-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64298", "termination_date": "20131101", "recall_initiation_date": "20130118", "postal_code": "90262-4022", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Princeton", "address_1": "600 College Rd E Ste 2100", "reason_for_recall": "Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.", "address_2": "", "product_quantity": "4,016 bottles", "code_info": "Lot #: RB93911, Exp 07/14", "center_classification_date": "20130212", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NJ", "product_description": "Lac-Hydrin (ammonium lactate) Lotion, 12%, packaged in 400 g bottles, Rx only, Ranbaxy, Jacksonville, FL 32257 USA, NDC 10631-098-14.", "report_date": "20130220", "classification": "Class III", "openfda": {}, "recalling_firm": "Ranbaxy Inc.", "recall_number": "D-162-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64286", "termination_date": "20140409", "more_code_info": "", "recall_initiation_date": "20121227", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64533", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Panama", "recall_number": "D-211-2013", "product_description": "4 way Saline Moisturizing Mist with Eucalyptol & Menthol, 1-fl. oz. bottles, OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.", "product_quantity": "227,124 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.", "recall_initiation_date": "20130307", "center_classification_date": "20130321", "termination_date": "20141126", "report_date": "20130327", "code_info": "Lot #: 10107922, 10108365, 10108366, 10108367, 10109874, 10110021, 10110022, 10110023, 10110024, and 10120729, Exp 3/14 to 9/14."}, {"country": "United States", "city": "Eatontown", "address_1": "465 Industrial Way W", "reason_for_recall": "Subpotent Drug", "address_2": "", "product_quantity": "1,185 Bottles", "code_info": "Lot #: 69001A", "center_classification_date": "20130212", "distribution_pattern": "OH", "state": "NJ", "product_description": "Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.", "report_date": "20130220", "classification": "Class III", "openfda": {}, "recalling_firm": "West-ward Pharmaceutical Corp.", "recall_number": "D-164-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64108", "termination_date": "20140516", "more_code_info": "", "recall_initiation_date": "20130107", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Herndon", "address_1": "607 Herndon Pkwy Ste 110", "reason_for_recall": "Defective Container: Pump head detaching from the canister unit upon removal of the overcap.", "address_2": "Ste 110", "product_quantity": "4, 835 bottles", "code_info": "Lot Number: EHAD Exp. 07/14", "center_classification_date": "20130204", "distribution_pattern": "Products were distributed nationwide.", "state": "VA", "product_description": "EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression,  for use as physician starter samples; product is labeled in part ***Manufactured for ASCEND Therapeutics Herndon, VA 20170 by DPT Laboratories San Antonio TX 78215***", "report_date": "20130213", "classification": "Class III", "openfda": {}, "recalling_firm": "Ascend Therapeutics Inc", "recall_number": "D-146-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64116", "termination_date": "20130607", "more_code_info": "", "recall_initiation_date": "20121119", "postal_code": "20170-5477", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Hollywood", "address_1": "2854 Stirling Rd", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, making this product an unapproved new drug.", "address_2": "Suite G", "product_quantity": "40,400 bottles", "code_info": "All Lots of SlimXtreme with the following format stamped in black ink on the bottom of the bottle \"MFD: XX.XX.20XX  EXP: XX.XX.20XX\", which were manufactured overseas, are being recalled.", "center_classification_date": "20130205", "distribution_pattern": "Nationwide and Puerto Rico and internationally to Barbados, Brazil, Canada, Cyprus, Equador, France, Germany, Israel, Mexico, and Netherlands.", "state": "FL", "product_description": "SLIM XTREME Herbal Slimming Capsule, supplied in 30-count bottles. Another Product Forumulated and Distributed By: Globe All Wellness, LLC Hollywood, FL 33020 www.diet66.com Inquires Call 877.842.9873", "report_date": "20130213", "classification": "Class I", "openfda": {}, "recalling_firm": "Globe All Wellness, LLC", "recall_number": "D-148-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "63048", "termination_date": "20191002", "more_code_info": "", "recall_initiation_date": "20120920", "postal_code": "33020-1138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Schaumburg", "address_1": "1501 E Woodfield Rd", "reason_for_recall": "Labeling: Missing label", "address_2": "Suite 300 East", "product_quantity": "155,900 vials domestically", "code_info": "Lot  6004889, Expiration Date 10/2014", "center_classification_date": "20130313", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "CALCIUM GLUCONATE INJECTION, USP, 10% (100 mg/mL), 10 mL, Single Dose Vial, Rx only, For Direct Slow IV or IV Additive Use Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- Product Code 31110, NDC 63323-311-10", "report_date": "20130320", "classification": "Class III", "openfda": {}, "recalling_firm": "Fresenius Kabi USA LLC (FK USA)", "recall_number": "D-200-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64266", "termination_date": "20131118", "more_code_info": "", "recall_initiation_date": "20130201", "postal_code": "60173-6052", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-109-2013", "product_description": "Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "9062 vials", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Arlington", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64109", "recalling_firm": "Belmora LLC", "address_1": "1805 Crystal Drive", "address_2": "Unit 303", "postal_code": "22202", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-136-2013", "product_description": "Flanax (aluminum hydroxide, magnesium hydroxide, and simethicone) Fast Acting Antacid, 200 mg/200 mg/20 mg, 12 fl oz (355 mL) bottles, Distributed by: Belmora LLC, PO Box 3063, Arlington, VA 22203, UPC 8 53030 00209 0, NDC 27854.101.01.", "product_quantity": "17,996 bottles", "reason_for_recall": "Defective Container: Product lacks tamper evident breakaway band on cap.", "recall_initiation_date": "20121218", "center_classification_date": "20130124", "termination_date": "20130405", "report_date": "20130130", "code_info": "Lot #: 1321, 1322, 1323, and 1324"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-117-2013", "product_description": "Glycerin 100% PF, 1mL, 2 mL, and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "165 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-110-2013", "product_description": "Methylprednisolone Acetate  40 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "5130 vials", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Hood River", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62237", "recalling_firm": "James G. Cole, Inc.", "address_1": "1020 Wasco St Ste D and K", "address_2": "N/A", "postal_code": "97031", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed nationwide and Canada", "recall_number": "D-129-2013", "product_description": "I-C Drops, Eye Cleansing Agent,  15 ml  ASN/Maxam P.O. Box 1277 Hood River, OR 97031", "product_quantity": "253 bottles", "reason_for_recall": "Lack of Assurance of Sterility: The product is being recalled because the product label does not state sterile in accordance with 21 CFR Part 200.50(a)(1), Ophthalmic Preparations and Dispensers, and it is not in compliance with 21 CFR Part 349, Ophthalmic Drug Products for Over-The-Counter Use.", "recall_initiation_date": "20120828", "center_classification_date": "20130116", "termination_date": "20130312", "report_date": "20130123", "code_info": "N/A"}, {"country": "United States", "city": "Fajardo", "address_1": "Road 195, Km 1.1", "reason_for_recall": "Failed Impurity/Degradation Specifications due to moisture ingress in individual bottles", "address_2": "Union Street", "product_quantity": "3155 bottles", "code_info": "0.45 mg: 505969A", "center_classification_date": "20130131", "distribution_pattern": "US Nationwide", "state": "PR", "product_description": "Femtrace 0.45 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by Pharmaceutics International Inc, Hunt Valley, MD 21031 for Warner Chilcott Company LLC, Fajardo, PR 00738", "report_date": "20130206", "classification": "Class III", "openfda": {}, "recalling_firm": "Warner Chilcott Company LLC", "recall_number": "D-142-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64014", "termination_date": "20150616", "more_code_info": "", "recall_initiation_date": "20121221", "postal_code": "00738", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-119-2013", "product_description": "Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "7055 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64533", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Panama", "recall_number": "D-208-2013", "product_description": "Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.", "product_quantity": "91,872/1-oz. tubes and  94,464/2-oz. tubes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.", "recall_initiation_date": "20130307", "center_classification_date": "20130321", "termination_date": "20141126", "report_date": "20130327", "code_info": "Lot #: a) 10109149, 10111499, 10117160, 10119603, and 10121763, Exp 4/13 to 8/13; b) 10109148, 10112258, 10113806, 10115615, 10117161, 10119604, 10119605, 10121782, and 10122762, Exp 3/13 to 9/13."}, {"country": "United States", "city": "Chester", "address_1": "12230 Iron Bridge Rd", "reason_for_recall": "CGMP Deviations: Pharmaceutical for injection was not manufactured according to Good Manufacturing Procedures.", "address_2": "Ste. C", "product_quantity": "126 vials", "code_info": "Lot #: 10292012:56, Exp 01/27/13 and 10302012:77, Exp 01/28/13", "center_classification_date": "20130308", "distribution_pattern": "Nationwide", "state": "VA", "product_description": "Medi-bolic Booster Injectable (methionine 8.3 mg/mL, choline chloride 16.6 mg/mL, inositol 16.6 mg/mL, cyanocobalamin USP [Vit B12] 0.33 mg/mL, chromium chloride 2.6 mg/mL), 30 mL multi-dose vials, Rx3 Compounding Pharmacy, 12230 Ironbridge Rd., Suite C, Chester, VA  23831.", "report_date": "20130320", "classification": "Class II", "openfda": {}, "recalling_firm": "RX South LLC DBA RX3 Pharmacy", "recall_number": "D-191-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64541", "termination_date": "20130325", "more_code_info": "", "recall_initiation_date": "20130122", "postal_code": "23831-1534", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63871", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-130-2013", "product_description": "Lisinopril Tablets, USP 40 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1270-01); b) 1000-count tablets per bottle (NDC 0143-1270-10); Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ  07724; and c) 1000-count tablets per bottle (NDC 24658-245-10); Rx only, Manufactured for: Blu Pharmaceuticals, Franklin, KY 42134; Manufactured By: West-ward Pharmaceutical Corp., Eatontown, N.J. 07724.", "product_quantity": "32,550 bottles", "reason_for_recall": "Presence of Foreign Substance: Uncharacteristic black spots identified as a food grade lubricant with trace amounts of foreign particulates and stainless steel inclusions have been found in the tablets.", "recall_initiation_date": "20121207", "center_classification_date": "20130118", "termination_date": "20140804", "report_date": "20130130", "code_info": "Lot #: a) and b) 69545A, 69546A, 69546B, Exp 10/15; 69547A, Exp 11/15; 69995A, 69999A, 69999B, 70000A, 70001A, 70002A, 70002B, 70003A, 70004A, Exp 02/16; c) 69548A, 69549A, Exp 11/15; 69877A, Exp 02/16"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64233", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-193-2013", "product_description": "Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (NDC 0093-4337-10), Rx only, Manufactured in India By: Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India - 382 210; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA  18960.", "product_quantity": "3,913 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.", "recall_initiation_date": "20130123", "center_classification_date": "20130308", "termination_date": "20140403", "report_date": "20130320", "code_info": "Lot # N03029, Exp 03/14", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62664", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distribution was nationwide and to Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-103-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "16,548/100-tablet bottles", "reason_for_recall": "Subpotent; 9-month stability interval", "recall_initiation_date": "20120725", "center_classification_date": "20121221", "termination_date": "20131114", "report_date": "20130102", "code_info": "Lot 1094098, exp. date 9/2012"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-122-2013", "product_description": "Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "8919 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Saint Joseph", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["HILLYARD ALCOHOL FREE FOAMING INSTANT HAND SANITIZER"], "generic_name": ["BENZALKONIUM CHLORIDE"], "manufacturer_name": ["Hillyard GMP"], "product_ndc": ["76402-403"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZALKONIUM CHLORIDE"], "rxcui": ["1038799"], "spl_id": ["25ec5420-cf0c-4632-a9a1-db09708d8666"], "spl_set_id": ["a066bd4e-8f1d-4dfe-8754-fc7fd5ae48f9"], "package_ndc": ["76402-403-06", "76402-403-03", "76402-403-02", "76402-403-82"], "is_original_packager": [true], "unii": ["F5UM2KM3W7"]}, "product_type": "Drugs", "event_id": "64020", "recalling_firm": "Hillyard GMP", "address_1": "421 N 2nd St", "address_2": "", "postal_code": "64504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distribution nationwide", "recall_number": "D-140-2013", "product_description": "HILLYARD, Alcohol Free Foaming Instant Hand Sanitizer, Benzalkonium Chloride 0.10%, 1.25 L plastic bottle, OTC, HILLYARD IDUSTRIES, St. Joseph, MO. 64502 NDC 76402-403-03", "product_quantity": "2,139 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: The product may be contaminated with bacteria.", "recall_initiation_date": "20121228", "center_classification_date": "20130131", "termination_date": "20140129", "report_date": "20130206", "code_info": "Lot 1025554, Exp: 03/14 and Lot 1030652, Exp: 09/14", "more_code_info": ""}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Superpotent (Multiple Ingredient) Drug: Complaint received of oversized tablets.", "address_2": "", "product_quantity": "897,379 bottles", "code_info": "Lot #: All that begin with the letter \"C\" a) C1160712C, Exp 12/13; b) C0930812A, C1110412A, C1141012B, C1160712A, Exp 12/13; c) C0950812B, C1110412B, C1151012B, C1160712B, C1530512A, Exp 12/13; d)  C0540212A, C0550212A, C0560212A, C0710312A, C0720312A, C0730112B, C0730312A, C0740112B, C0740312A, C0750112A, C0760112A, C0770112C, C0780112C, C0790112C, C0860812A, C0870812A, C0880812A, C0890812A, C0900812A, C0910812A, C0920812A, C0950412A, C0950812D, C0960412A, C0970412A, C0980412A, C1030412A, C1040412A, C1050412A, C1060412A, C1061012A, C1070412A, C1071012A, C1081012A, C1101012A, C1111012A, C1120412A, C1121012A, C1130412A, C1131012A, C1140412A, C1141012A, C1160712D, C1440512A, C1450512A, C1460512A, C1470512A, C1510512A, C1520512A, C1530512B, C1540512A, C1550512A, C1560512A, C1570512A, Exp 12/13; e) C0670312A, C0680312A, C0930812B, C0950812C, Exp 12/13; f) C1160712E, Exp 12/13; g) C0950812A, C1110412C, Exp 12/13; h) C0630212B, C0640212B, C0690312A, C0700312A, C0720112B,C0940812A, C0941112A, C0960812A, C1010412B, C1020412B, C1080412A, C1090412A, C1100412A, C1170712A, C1180712A, C1480512A, C1490512A, C1500512A, Exp 12/13; i) C0570212B, C0580212B, C0590212B, C0600212A, C0610212A, C0620212A, C0750312A, C0760312A, C0930812C, C0970812A, C0990412A, C1000412A, Exp 12/13", "center_classification_date": "20130130", "distribution_pattern": "Nationwide and Puerto Rico", "state": "AL", "product_description": "Hydrocodone bitartrate and acetaminophen Tablets, USP, 10 mg/500 mg, packaged in a) 30-count bottles, NDC 0603-3888-16; b) 60-count bottles, NDC 0603-3888-20; c) 90-count bottles, NDC 0603-3888-02; d) 100-count bottles, NDC 0603-3888-21; e) 120-count bottles, NDC 0603-3888-22; f) 150-count bottles, NDC 0603-3888-26; g) 180-count bottles, NDC 0603-3888-04; h) 500-count bottles, NDC 0603-3888-28; and i) 1000-count bottles, NDC 0603-3888-32, Rx only, Mfg. for: Qualitest Pharmaceuticals, Huntsville, AL 35811.", "report_date": "20130206", "classification": "Class I", "openfda": {}, "recalling_firm": "Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals", "recall_number": "D-138-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "63818", "termination_date": "20210720", "more_code_info": "", "recall_initiation_date": "20121206", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64482", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-206-2013", "product_description": "METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag,  Rx only, Hospira, Inc. Lake Forest, IL 60045 (NDC 0409-7811-24)", "product_quantity": "567,624 bags", "reason_for_recall": "Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.", "recall_initiation_date": "20130215", "center_classification_date": "20130321", "termination_date": "20150331", "report_date": "20130327", "code_info": "Lot code 12-074-JT Exp 12/13"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077750"], "brand_name": ["CABERGOLINE"], "generic_name": ["CABERGOLINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5420"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CABERGOLINE"], "rxcui": ["199703"], "spl_id": ["ee38a597-4dd9-4b40-b168-97e919ead1c7"], "spl_set_id": ["74b61e8a-7ae9-4996-85ec-df23c56de16f"], "package_ndc": ["0093-5420-88"], "is_original_packager": [true], "nui": ["M0007652", "N0000175827"], "pharm_class_cs": ["Ergolines [CS]"], "pharm_class_epc": ["Ergot Derivative [EPC]"], "unii": ["LL60K9J05T"]}, "product_type": "Drugs", "event_id": "61725", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-128-2013", "product_description": "CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88", "product_quantity": "13,232 bottles", "reason_for_recall": "Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life", "recall_initiation_date": "20120424", "center_classification_date": "20130116", "termination_date": "20131218", "report_date": "20130123", "code_info": "Lot number 6A007046V, exp 07/12"}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64151", "recalling_firm": "Actelion Pharmaceuticals U.S., Inc.", "address_1": "5000 Shoreline Ct. Ste 200", "address_2": "N/A", "postal_code": "94080-1956", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA & VA", "recall_number": "D-143-2013", "product_description": "Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30.", "product_quantity": "3 Cartons", "reason_for_recall": "Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.", "recall_initiation_date": "20130116", "center_classification_date": "20130201", "termination_date": "20130723", "report_date": "20130213", "code_info": "Lot #: MA00AD5, Exp: 11/30/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64056", "recalling_firm": "Watson Pharmaceuticals", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-145-2013", "product_description": "Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90.", "product_quantity": "3,040 bottles", "reason_for_recall": "Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).", "recall_initiation_date": "20121218", "center_classification_date": "20130204", "termination_date": "20140730", "report_date": "20130213", "code_info": "Lot #: 512146A, Exp 01/31/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Rocky Mount", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018667"], "brand_name": ["FUROSEMIDE"], "generic_name": ["FUROSEMIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-6102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FUROSEMIDE"], "rxcui": ["1719286", "1719290", "1719291"], "spl_id": ["0d4a39f2-904e-434a-9af1-83bb4febf124"], "spl_set_id": ["39fd32f2-6bb7-4a65-d298-e48d26bc80c7"], "package_ndc": ["0409-6102-19", "0409-6102-02", "0409-6102-18", "0409-6102-04", "0409-6102-20", "0409-6102-10"], "is_original_packager": [true], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["7LXU5N7ZO5"]}, "product_type": "Drugs", "event_id": "64083", "recalling_firm": "Hospira, Inc.", "address_1": "Hwy. 301 N. + 4285 North Wesleyan Blvd.", "address_2": "N/A", "postal_code": "27804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-169-2013", "product_description": "Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04", "product_quantity": "63,900 vials", "reason_for_recall": "Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial", "recall_initiation_date": "20130110", "center_classification_date": "20130226", "termination_date": "20141008", "report_date": "20130306", "code_info": "18-099-DK"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63285", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-180-2013", "product_description": "Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli,  India 502 325, NDC 55111-344-30", "product_quantity": "48, 754 bottles (C108376)/47,520 bottles (C108634)", "reason_for_recall": "Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.", "recall_initiation_date": "20120801", "center_classification_date": "20130228", "termination_date": "20130524", "report_date": "20130306", "code_info": "Lot #:  C108376, C108634, Exp 11/13"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63871", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-131-2013", "product_description": "Propylthiouracil Tablets, USP, 50 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1480-01) and b) 1000-count tablets per bottle (NDC 0143-1480-10), Rx only, Manufactured by: West-ward Pharmaceuticals Corp. Eatontown, NJ 07724.", "product_quantity": "43,075 bottles", "reason_for_recall": "Presence of Foreign Substance: Uncharacteristic spots identified as steel corrosion, degraded tablet material and hydrocarbon oil with trace amounts of iron were found in tablets.", "recall_initiation_date": "20121207", "center_classification_date": "20130118", "termination_date": "20140804", "report_date": "20130130", "code_info": "Lot #: 68478A, 69059A, 69059B, Exp 01/16"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-123-2013", "product_description": "Saline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "54 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"country": "United States", "city": "Lynwood", "address_1": "11865 Alameda St", "reason_for_recall": "Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.  If the product is shaken or warmed the white particles goes into the solution.", "address_2": "11840 S Alameda ST", "product_quantity": "5,676 bottles (473 cases)", "code_info": "Lot# 71648, 68088;  FP-47-041-02535", "center_classification_date": "20130307", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Select Brand Cough Control CF Max, Maximum Strength for MUCUS RELIEF, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg), 4 fl.oz 12pk (NDC 15127-025-04; UPC Code: 0-15127-02535-5), Distributed by: Select Brand Distributors, Pine Bluff, AR 71603 USA.", "report_date": "20130313", "classification": "Class III", "openfda": {}, "recalling_firm": "Aaron Industries Inc", "recall_number": "D-187-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64298", "termination_date": "20131101", "recall_initiation_date": "20130118", "postal_code": "90262-4022", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Fullerton", "address_1": "1941 W Commonwealth Ave", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: All lots of the dietary supplement Slimdia Revolution are being recalled because they contain sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.", "address_2": "Suite B", "product_quantity": "unknown", "code_info": "There are no manufacturing codes associated with the product.", "center_classification_date": "20130215", "distribution_pattern": "Korea", "state": "CA", "product_description": "SLIMDIA Revolution capsules, 30-count capsules per bottle, Yerba Naturals, 19685 Varda Ave., Buena Park, CA.", "report_date": "20130227", "classification": "Class I", "openfda": {}, "recalling_firm": "P & J Trading Co", "recall_number": "D-165-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "63942", "termination_date": "20130325", "recall_initiation_date": "20121219", "postal_code": "92833-3042", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Humacao", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021436"], "brand_name": ["ABILIFY"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Otsuka America Pharmaceutical, Inc."], "product_ndc": ["59148-006", "59148-007", "59148-008", "59148-009", "59148-010", "59148-011"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "352307", "352308", "352309", "352310", "402131", "404602", "602964", "615172"], "spl_id": ["1b189d15-798d-4bed-a93d-a543ed7abd81"], "spl_set_id": ["c040bd1d-45b7-49f2-93ea-aed7220b30ac"], "package_ndc": ["59148-006-13", "59148-006-92", "59148-007-13", "59148-007-35", "59148-007-94", "59148-008-13", "59148-008-35", "59148-008-95", "59148-009-13", "59148-009-35", "59148-009-95", "59148-010-13", "59148-010-35", "59148-011-13", "59148-011-35"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "63706", "recalling_firm": "Bristol Myers Squibb Manufacturing Company", "address_1": "Rd #3 Km 77.5", "address_2": "N/A", "postal_code": "00792", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "LA, TN, CA", "recall_number": "D-181-2013", "product_description": "ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35", "product_quantity": "21 blister packs", "reason_for_recall": "CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.", "recall_initiation_date": "20121102", "center_classification_date": "20130304", "termination_date": "20130502", "report_date": "20130313", "code_info": "2E69023A, Exp. FEB 28 2015"}, {"country": "United States", "city": "Monroe Township", "address_1": "259 Prospect Plains Road", "reason_for_recall": "Presence of Particulate Matter; fibers identified as cellulose and polyvinyl", "address_2": "Building H", "product_quantity": "5483 syringes (548.3 boxes)", "code_info": "Lot #: 9K37791, Exp 11/12; 9L40746, Exp 12/12; 0A43705, Exp 01/13; 0C57509, 0C57521, Exp 03/13; 0E62913, Exp 05/13", "center_classification_date": "20130207", "distribution_pattern": "Nationwide.", "state": "NJ", "product_description": "Isovue -370 (Iopamidol) Injection 76%, Prefilled 10 x 75 mL (NDC 0270-1316-66), 10 x 100 mL (NDC 0270-1316-67), 10 x 125 mL (NDC 0270-1316-68) Power Injector Syringe, Rx Only, Manufactured for Bracco Diagnostics Inc., Princeton, NJ 08543 by Nycomed GmbH 78224 Singen (Germany).", "report_date": "20130213", "classification": "Class I", "openfda": {}, "recalling_firm": "Bracco Diagnostic Inc", "recall_number": "D-157-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63765", "termination_date": "20150706", "more_code_info": "", "recall_initiation_date": "20121121", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63971", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-133-2013", "product_description": "PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.", "product_quantity": "60,289 bottles", "reason_for_recall": "Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.", "recall_initiation_date": "20121205", "center_classification_date": "20130118", "termination_date": "20140516", "report_date": "20130130", "code_info": "Lot #: 68581A, 68581B, 68382A, 68382B, 68578A, 68578B, 68579A, 68580A, 68582A, 68582B, Exp 01/15"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-124-2013", "product_description": "Triamcinolone 10 mg/mL P,  40mg/mL P, 40mg/mL PF and 80 mg/mL PF in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "56,655 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64104", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-201-2013", "product_description": "Carisoprodol Tablets, USP, 350 mg Rx Only, 100 tablets per bottle, Rx Only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724, NDC 0143-1176-01.", "product_quantity": "1763 bottles", "reason_for_recall": "Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance.  This product is being recalled because this controlled product was not relabeled with the required \"C-IV\" imprint on the label for products distributed after the 06/11/12 deadline.", "recall_initiation_date": "20121130", "center_classification_date": "20130315", "termination_date": "20141218", "report_date": "20130327", "code_info": "Lot #: 69160A"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64107", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-170-2013", "product_description": "Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC 143-1140-51); Rx only,  Manufactured by: West-ward Pharmaceutical Corp. Eatontown, NJ 07724", "product_quantity": "6,511 bottles", "reason_for_recall": "Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.", "recall_initiation_date": "20130107", "center_classification_date": "20130227", "termination_date": "20150121", "report_date": "20130306", "code_info": "Lot #: 69099A, 69099B, Exp 08/15"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64001", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-183-2013", "product_description": "0.9% Sodium Chloride Injection USP, 100 mL   Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,", "product_quantity": "325,056 bags", "reason_for_recall": "Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.", "recall_initiation_date": "20130108", "center_classification_date": "20130307", "termination_date": "20150515", "report_date": "20130313", "code_info": "Lot Number 02-117-JT Exp. 02/13"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-121-2013", "product_description": "Lidocaine 1% PF, 2% PF, and 4% PF, in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "3,321 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Completed", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA076517"], "brand_name": ["CARBOPLATIN"], "generic_name": ["CARBOPLATIN"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CARBOPLATIN"], "rxcui": ["597195"], "spl_id": ["0ddf4411-7138-412a-908a-fadf22bdfb79"], "spl_set_id": ["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"], "package_ndc": ["61703-339-18", "61703-339-22", "61703-339-50", "61703-339-56", "61703-360-50"], "is_original_packager": [true], "nui": ["N0000175413", "N0000175073"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "unii": ["BG3F62OND5"]}, "product_type": "Drugs", "event_id": "63548", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-154-2013", "product_description": "Carboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, NDC 61703-339-50 (Hospira label) and NDC 61703-360-50 (Novaplus label), Hospira, Inc., Lake Forest, IL 60045, Product of Australia.", "product_quantity": "31,326 vials", "reason_for_recall": "Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.", "recall_initiation_date": "20121108", "center_classification_date": "20130206", "termination_date": "20170320", "report_date": "20130213", "code_info": "lots Z011711AA (Hospira label) and Z011711AB (Novaplus label), Exp. 08/2013", "more_code_info": ""}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63258", "recalling_firm": "Genentech Inc", "address_1": "1 DNA Way", "address_2": "N/A", "postal_code": "94080-4990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-135-2013", "product_description": "Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial Bacteriostatic Water for Injection, USP (1.1% benzyl alcohol), Manufactured by Hospira, Inc., for Genentech, Inc., South San Francisco, CA  94080-4990, NDC 50242-903-69; and 1 Reconstitution Instructions per kit; Investigation Use only, Genentech, Inc., 1 DNA Way, South San Francisco, CA  94080-4990.", "product_quantity": "2,140 kits", "reason_for_recall": "Presence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials that were packed with Trastuzumab Kits for investigational use has the potential to contain glass particulates.", "recall_initiation_date": "20120730", "center_classification_date": "20130122", "termination_date": "20130325", "report_date": "20130130", "code_info": "Lot #: 454138, Exp 07/14 (containing Trastuzumab Lot #: 886618, Exp 12/14; and Bacteriostatic Water for Injection, USP Lot #: 08-368-DK-01, Exp 07/14)"}, {"country": "United States", "city": "Las Piedras", "address_1": "Pridco Industrial Park", "reason_for_recall": "Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.", "address_2": "Road # 183", "product_quantity": "17,169 Packages", "code_info": "Lot: 0NCW005, Exp 02/2013", "center_classification_date": "20130130", "distribution_pattern": "Nationwide and Puerto Rico", "state": "PR", "product_description": "Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033", "report_date": "20130206", "classification": "Class II", "openfda": {}, "recalling_firm": "Schering-Plough Products, LLC", "recall_number": "D-139-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63879", "termination_date": "20140103", "more_code_info": "", "recall_initiation_date": "20121212", "postal_code": "00771", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63285", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-178-2013", "product_description": "Citalopram tablets USP, 10mg, 30-count bottle,  Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli,  India 502 325, NDC 55111-342-30", "product_quantity": "27,805 bottles", "reason_for_recall": "Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.", "recall_initiation_date": "20120801", "center_classification_date": "20130228", "termination_date": "20130524", "report_date": "20130306", "code_info": "Lot #: C201028, Exp 12/13"}, {"status": "Terminated", "city": "Broomfield", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64118", "recalling_firm": "Sandoz Incorporated", "address_1": "2555 W Midway Blvd", "address_2": "N/A", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-152-2013", "product_description": "Syeda (drospirenone and ethinyl estradiol), 3 mg/0.03 mg, 3 x 28 tablet blistercards, combination oral contraceptive tablet, Manufactured by Laboratorios Leon Farma S.A., Spain for Sandoz Inc., Princeton, NJ", "product_quantity": "17,188 cartons containing 3 cards each.", "reason_for_recall": "Tablet/Capsule Imprinted with Wrong ID; a portion of the tablets could contain the incorrect debossing on one side of the tablet U2 instead of U3.", "recall_initiation_date": "20130122", "center_classification_date": "20130206", "termination_date": "20130507", "report_date": "20130213", "code_info": "LF01215A, Exp 02/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Scottsdale", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63917", "recalling_firm": "Matrixx Initiatives Inc", "address_1": "8515 E Anderson Dr", "address_2": "N/A", "postal_code": "85255-5461", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-155-2013", "product_description": "Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona  85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.", "product_quantity": "46,752 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.", "recall_initiation_date": "20121218", "center_classification_date": "20130207", "termination_date": "20131114", "report_date": "20130213", "code_info": "Lot # 2J23, Exp 09/15", "more_code_info": ""}, {"country": "United States", "city": "Lynwood", "address_1": "11865 Alameda St", "reason_for_recall": "Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.  If the product is shaken or warmed the white particles goes into the solution.", "address_2": "11840 S Alameda ST", "product_quantity": "43,464 bottles (3,622 cases)", "code_info": "Lot# 81198, 82183, 80797;  FP-44-081-03884,", "center_classification_date": "20130307", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Wal-Mart Equate Tussin CF Adult Maximum Strength, Multi-Symptom Cold, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg), 8 FL OZ (235 mL) (NDC 49035-229-08; UPC Code: 6-81131-03884-30), Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72712.", "report_date": "20130313", "classification": "Class III", "openfda": {}, "recalling_firm": "Aaron Industries Inc", "recall_number": "D-188-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64298", "termination_date": "20131101", "recall_initiation_date": "20130118", "postal_code": "90262-4022", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63589", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-106-2013", "product_description": "Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01", "product_quantity": "361,600/1-mL ampules", "reason_for_recall": "Presence of Particulates; may contain glass particles", "recall_initiation_date": "20121025", "center_classification_date": "20121228", "termination_date": "20141015", "report_date": "20130109", "code_info": "Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63510", "recalling_firm": "Estee Lauder Inc", "address_1": "767 5th Ave Fl 47th", "address_2": "N/A", "postal_code": "10153-0023", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide, Puerto Rico, Bermuda and Panama", "recall_number": "D-151-2013", "product_description": "ESTEE LAUDER DayWear Sheer Tint Release, Advanced Multi-Protection Anti-Oxidant  Moisturizer Broad Spectrum SPF15, All Skin types, 1.7 FL. OZ. LIQ/50 ml (tube inside a unit carton) with UPC No. 2713179904, Code WKEM-01, and 1.5 mL foil sample packets,  ESTEE LAUDER, DIST., NEW YORK, N.Y. 10022 NDC 11559-008-01", "product_quantity": "1.7 oz. 241,236 tubes; 1.5 mL sample size 544,548  foil packs", "reason_for_recall": "Failed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than labeled.", "recall_initiation_date": "20121023", "center_classification_date": "20130205", "termination_date": "20170403", "report_date": "20130213", "code_info": "A70, A80, AA0, B11, A31, A51, B51, A81, A91, A12, A22, A72, BA0, AB0, BB0, CB0, AC0, BC0, A11, A21, B21, B31, A41.", "more_code_info": ""}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63846", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 100", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "OH, GA", "recall_number": "D-214-2013", "product_description": "Levothyroxine Tablets, USP (levothyroxine sodium), 0.175 mg, 30 count bottles, Rx, Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK  --- NDC 54868-4507-00", "product_quantity": "90 pills", "reason_for_recall": "Subpotent; 15 month stability (by mfr)", "recall_initiation_date": "20121115", "center_classification_date": "20130321", "termination_date": "20130701", "report_date": "20130327", "code_info": "6WX2 exp 12/31/2012"}, {"status": "Terminated", "city": "Lynnwood", "state": "WA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62908", "recalling_firm": "Bayer HealthCare Pharmaceuticals Inc.", "address_1": "2625 162nd St SW", "address_2": "N/A", "postal_code": "98087", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-156-2013", "product_description": "Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2", "product_quantity": "138,505 vials", "reason_for_recall": "Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.", "recall_initiation_date": "20120531", "center_classification_date": "20130207", "termination_date": "20130510", "report_date": "20130213", "code_info": "B18511 Exp. 04/12 , B18513 Exp. 05/12, B18515 Exp. 06/12, B18517 Exp. 06/12, B18825 Exp. 10/12, B18831 Exp.12/12", "more_code_info": ""}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-112-2013", "product_description": "Betamethasone Repository 6 mg/mL PF Injection and Betamethasone Repository 6 mg/mL P Injection, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"country": "United States", "city": "Monroe Township", "address_1": "259 Prospect Plains Road", "reason_for_recall": "Presence of Particulate Matter; fibers identified as cellulose and polyvinyl", "address_2": "Building H", "product_quantity": "5736 syringes (573.6 boxes)", "code_info": "Lot #: 9K34572, Exp 11/12; 0A43282, Exp 01/13; 0C56283,  Exp 03/13", "center_classification_date": "20130207", "distribution_pattern": "Nationwide.", "state": "NJ", "product_description": "Isovue -300 (Iopamidol) Injection 61% Prefilled, 10 x 100 mL Power Injector Syringe, Rx Only, Manufactured for Bracco Diagnostics Inc., Princeton, NJ 08543 by Nycomed GmbH 78224 Singen (Germany); NDC 0270-1315-67.", "report_date": "20130213", "classification": "Class I", "openfda": {}, "recalling_firm": "Bracco Diagnostic Inc", "recall_number": "D-158-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63765", "termination_date": "20150706", "more_code_info": "", "recall_initiation_date": "20121121", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Spring", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "59001", "recalling_firm": "A B Nutrition, Inc.", "address_1": "5407 Louetta, Suite E", "address_2": "N/A", "postal_code": "77379", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "In retail store located in TX and internet sales nationwide.", "recall_number": "D-194-2013", "product_description": "PIRACETAM COGNITION ENHANCING AGENT Dietary Supplement PHARMACEUTICAL GRADE 800 mg 240 Capsules per bottle CTD Labs Houston, TX 77090", "product_quantity": "2980 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: The product is an unapproved new drug.", "recall_initiation_date": "20110527", "center_classification_date": "20130308", "termination_date": "20130729", "report_date": "20130320", "code_info": "Lot #33250311 Exp. 04/13", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63966", "recalling_firm": "L. Perrigo Co.", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-125-2013", "product_description": "Prednisone tablets, USP, 10mg, Rx Only, Units of Use, NDC: a) 45802-303-67, 48-count Cartons, b) 45802-303-21, 21-count Cartons, Manufactured by: West-Ward Pharmaceutical Corporation, Eastown, NJ 07724, Distributed by: Perrigo, Allegan, MI 49040.", "product_quantity": "86,616 Tablets", "reason_for_recall": "Presence of Foreign Substance(s); Perrigo has been notified of a recall by the manufacturer of this product, West-Ward Pharmaceuticals. This is a sub-recall due to tablets contaminated with trace amounts of food-grade lubricant, as well as stainless steel inclusions", "recall_initiation_date": "20121217", "center_classification_date": "20130114", "termination_date": "20140106", "report_date": "20130123", "code_info": "Lot #s:  a) 2DV1238, Exp10/13; 2CV0623, 2CV0625, Exp 11/13; b) 2DV1239, Exp 10/13; 2CV0627, Exp 11/13"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62664", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distribution was nationwide and to Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-101-2013", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01,   Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "37,441/100-tablet bottles", "reason_for_recall": "Subpotent; 9-month stability interval", "recall_initiation_date": "20120725", "center_classification_date": "20121221", "termination_date": "20131114", "report_date": "20130102", "code_info": "Lot 1093992 and 1094095, exp. date 9/2012"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63899", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-166-2013", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 blistered tablets per carton, Rx only; Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, Pkg by &amp;amp; Distributed by UDL Laboratories, Inc., Rockford, IL 61103; NDC 51079-254-21.", "product_quantity": "3,407 cartons", "reason_for_recall": "Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.", "recall_initiation_date": "20121214", "center_classification_date": "20130215", "termination_date": "20160809", "report_date": "20130227", "code_info": "Lot #: 3037841, 3040859, 3042573, Exp 12/13"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64312", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-203-2013", "product_description": "Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only;  Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 9591-5239-01", "product_quantity": "9,824 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate  because an out of specification result for an impurity diphenyl sulfone .", "recall_initiation_date": "20130208", "center_classification_date": "20130319", "termination_date": "20140131", "report_date": "20130327", "code_info": "386585A, Exp. 02/13; 429104A, Exp. 06/13; 474487A, Exp. 11/13; 491671A, Exp.01/14."}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64105", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA", "recall_number": "D-189-2013", "product_description": "VERSAPHARM Ethambutol Tablets, USP,400 mg,  Rx Only     a)60 tablets, NDC 61748-014-06, b)90 tablets, NDC 61748-014-09, c)100 tablets, NDC 61748-014-01, d)1000 tablets, NDC 61748-014-10, e) blister pack (10s) 61748-014-11  Manufactured for: VersaPharm Incorporated   Marietta, GA 30062-2260,  Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.", "product_quantity": "18,825 bottles", "reason_for_recall": "Discoloration: Ethambutol Tablets USP 400 mg have tablets cores that may be discolored.", "recall_initiation_date": "20121130", "center_classification_date": "20130307", "termination_date": "20140114", "report_date": "20130313", "code_info": "68977A; 68977B; 68978B; 68978C;  68979A - exp JUL 2015      68977C; 68978A  exp JUL 2013"}, {"country": "United States", "city": "Princeton", "address_1": "600 College Rd E Ste 2100", "reason_for_recall": "Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.", "address_2": "", "product_quantity": "6,535 tubes and bottles", "code_info": "Lot #: RB91881, Exp 07/14; RB91891, Exp 07/13", "center_classification_date": "20130212", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NJ", "product_description": "Lac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 g bottle, NDC 10631-099-38; Rx only, Ranbaxy, Jacksonville, FL 32257 USA.", "report_date": "20130220", "classification": "Class III", "openfda": {}, "recalling_firm": "Ranbaxy Inc.", "recall_number": "D-163-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64286", "termination_date": "20140409", "more_code_info": "", "recall_initiation_date": "20121227", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Spring", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "59001", "recalling_firm": "A B Nutrition, Inc.", "address_1": "5407 Louetta, Suite E", "address_2": "N/A", "postal_code": "77379", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "In retail store located in TX and internet sales nationwide.", "recall_number": "D-195-2013", "product_description": "PIRACETAM POWDER COGNITION ENHANCING AGENT Dietary Supplement CTD 500 grams PHARMACEUTICAL GRADECTD Labs Houston, TX 77090", "product_quantity": "509 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: The product is an unapproved new drug.", "recall_initiation_date": "20110527", "center_classification_date": "20130308", "termination_date": "20130729", "report_date": "20130320", "code_info": "Lot # 33280311 Exp. 03/13", "more_code_info": ""}, {"status": "Terminated", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020929"], "brand_name": ["PULMICORT RESPULES"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0186-1988", "0186-1989", "0186-1990"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["BUDESONIDE"], "rxcui": ["252559", "349094", "351109", "616817", "616819", "616830"], "spl_id": ["76a8044c-b6f4-4da4-b855-a281fdca66b4"], "spl_set_id": ["33cd9834-76df-4f26-3fa2-aab6b9eee8f2"], "package_ndc": ["0186-1988-04", "0186-1989-04", "0186-1990-04"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "64041", "recalling_firm": "AstraZeneca LP", "address_1": "50 Otis Street", "address_2": "N/A", "postal_code": "01581-4500", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-199-2013", "product_description": "PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton)  Budesonide Inhalation Suspension  NDC: 0186-1989-04", "product_quantity": "64675 cartons", "reason_for_recall": "Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.", "recall_initiation_date": "20130111", "center_classification_date": "20130312", "termination_date": "20130726", "report_date": "20130320", "code_info": "Lot/Exp Date:  YP0035 11/13; YP0140 12/13; YP0136 12/13; AB0077  2/14;  AH0133  5/14", "more_code_info": ""}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-113-2013", "product_description": "Betamethasone Sodium Phosphate  6 mg/mL P Injection, Betamethasone Sodium Phosphate  6 mg/mL PF Injection, Betamethasone Sodium Phosphate  8 mg/mL PF Injection, Betamethasone Sodium Phosphate  12 mg/mL PF Injection, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"country": "United States", "city": "Horsham", "address_1": "2 Walnut Grove Dr", "reason_for_recall": "Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.", "address_2": "Suite 190", "product_quantity": "12,948 bottles", "code_info": "Lot 220839, exp 11/30/2013", "center_classification_date": "20130227", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "PA", "product_description": "Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-328-09", "report_date": "20130306", "classification": "Class II", "openfda": {}, "recalling_firm": "Amedra Pharmaceuticals LLC", "recall_number": "D-172-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63926", "termination_date": "20140321", "recall_initiation_date": "20121204", "postal_code": "19044-2219", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA076517"], "brand_name": ["CARBOPLATIN"], "generic_name": ["CARBOPLATIN"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CARBOPLATIN"], "rxcui": ["597195"], "spl_id": ["0ddf4411-7138-412a-908a-fadf22bdfb79"], "spl_set_id": ["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"], "package_ndc": ["61703-339-18", "61703-339-22", "61703-339-50", "61703-339-56"], "is_original_packager": [true], "nui": ["N0000175413", "N0000175073"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "unii": ["BG3F62OND5"]}, "product_type": "Drugs", "event_id": "63548", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-153-2013", "product_description": "Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, Hospira, Inc., Lake Forest, IL 60045, Product of Australia, NDC 61703-339-56.", "product_quantity": "23,315 vials", "reason_for_recall": "Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.", "recall_initiation_date": "20121108", "center_classification_date": "20130206", "termination_date": "20170320", "report_date": "20130213", "code_info": "Lot #: Z021650AA, Exp. 08/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64338", "recalling_firm": "Glenmark Generics Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-182-2013", "product_description": "Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b) 90-count tablets per bottle (NDC 68462-392-90), Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430.", "product_quantity": "591,972 bottles", "reason_for_recall": "Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).", "recall_initiation_date": "20130213", "center_classification_date": "20130305", "termination_date": "20141009", "report_date": "20130313", "code_info": "02122956, 02123226, 02123269, 02123480, 02123481,  02122933, 02122955, 02123062, 02123075, 02123085,  02123114, 02123115, 02123124, 02123125, 02123189,  02123199, 02123205, 02123219, 02123253, 02123270,  02123289, 02123295, 02123320, 02123333, 02123343,  02123349, 02123411, 02123421, 02123431, Exp 09/14 and 10/14"}, {"status": "Terminated", "city": "San Juan", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63608", "recalling_firm": "Alara Pharmaceutical Co", "address_1": "270 Ave Munoz Rivera #301", "address_2": "N/A", "postal_code": "00918", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-104-2013", "product_description": "Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR", "product_quantity": "7,432 bottles", "reason_for_recall": "Subpotent; 15 month stability", "recall_initiation_date": "20121029", "center_classification_date": "20121221", "termination_date": "20140103", "report_date": "20130102", "code_info": "11T7011A, Exp. Date: 12/2012"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64154", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-137-2013", "product_description": "Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-3633-05, UPC 3 0378-3633-05 3.", "product_quantity": "11,580 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.", "recall_initiation_date": "20130116", "center_classification_date": "20130128", "termination_date": "20131205", "report_date": "20130206", "code_info": "Lot #: ZCMH12031, ZCMH12032, ZCMH12033, ZCMH12034, Exp 02/14", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63952", "recalling_firm": "Boehringer Ingelheim Roxane Inc", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-126-2013", "product_description": "Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane Laboratories Inc., Columbus, OH 43216, NDC 0054-0112-25.", "product_quantity": "3,553 bottles", "reason_for_recall": "Impurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.", "recall_initiation_date": "20121212", "center_classification_date": "20130116", "termination_date": "20140616", "report_date": "20130123", "code_info": "Lot #160017A, Exp 04/2013."}, {"status": "Terminated", "city": "Telford", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62983", "recalling_firm": "Axcentria Pharmaceuticals LLC", "address_1": "306 Keystone Dr", "address_2": "Unit B", "postal_code": "18969", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI", "recall_number": "D-134-2013", "product_description": "Major Oral Peroxide (Carbamide Peroxide 10%), 2 fl oz (60 mL), Distributed by: Major Pharmaceuticals 31778 Enterprise Drive, Livonia, MI 48150, NDC 0904-4062-03", "product_quantity": "17,679 bottles", "reason_for_recall": "Stability data does not support expiration date:  Stability data indicates the Carbamide Peroxide will degrade below acceptable levels within the 24-month expiration date printed on the packaging.", "recall_initiation_date": "20120817", "center_classification_date": "20130118", "termination_date": "20141007", "report_date": "20130130", "code_info": "Lot #s  L11065, exp 12/2013; B12019, exp 2/2014; B12020, exp 2/2014; and D12035, exp 4/2014."}, {"country": "United States", "city": "Fajardo", "address_1": "Road 195, Km 1.1", "reason_for_recall": "Failed Impurity/Degradation Specifications due to moisture ingress in individual bottles", "address_2": "Union Street", "product_quantity": "5439 bottles", "code_info": "0.9 mg: 512348A", "center_classification_date": "20130131", "distribution_pattern": "US Nationwide", "state": "PR", "product_description": "Femtrace 0.9 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by Pharmaceutics International Inc, Hunt Valley, MD 21031 for Warner Chilcott Company LLC, Fajardo, PR 00738", "report_date": "20130206", "classification": "Class III", "openfda": {}, "recalling_firm": "Warner Chilcott Company LLC", "recall_number": "D-141-12013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64014", "termination_date": "20150616", "more_code_info": "", "recall_initiation_date": "20121221", "postal_code": "00738", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090763"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-8015", "0378-8030"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["311277", "596843"], "spl_id": ["810def72-c1da-4c4d-9939-32b29be79e0c"], "spl_set_id": ["c8fa7401-907f-41b6-a2e1-f4bc214f2cdf"], "package_ndc": ["0378-8015-93", "0378-8030-93", "0378-8030-77", "0378-8030-05"], "is_original_packager": [true], "upc": ["0303788030932", "0303788015939"], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "64186", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-147-2013", "product_description": "Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.", "product_quantity": "1,894 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.", "recall_initiation_date": "20130130", "center_classification_date": "20130205", "termination_date": "20131223", "report_date": "20130213", "code_info": "Lot #: 1110829, Exp 05/14", "more_code_info": ""}, {"country": "United States", "city": "Horsham", "address_1": "2 Walnut Grove Dr", "reason_for_recall": "Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.", "address_2": "Suite 190", "product_quantity": "10,968 bottles", "code_info": "Lot 220843, exp 11/30/2013", "center_classification_date": "20130227", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "PA", "product_description": "Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-329-09", "report_date": "20130306", "classification": "Class II", "openfda": {}, "recalling_firm": "Amedra Pharmaceuticals LLC", "recall_number": "D-173-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63926", "termination_date": "20140321", "recall_initiation_date": "20121204", "postal_code": "19044-2219", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-114-2013", "product_description": "Bupivacaine 0.25% PF, Bupivacaine 0.5% PF, and Bupivacaine 0.75% PF, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"country": "United States", "city": "Lynwood", "address_1": "11865 Alameda St", "reason_for_recall": "Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.  If the product is shaken or warmed the white particles goes into the solution.", "address_2": "11840 S Alameda ST", "product_quantity": "6,108 bottles (509 cases)", "code_info": "Lot# 80798;  FP-49-081-14870,", "center_classification_date": "20130307", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Well at Walgreens Wal-Tussin CF Max, MAXIMUM STRENGTH ADULT NON-DROWSY, Multi-Symptom Cold, (dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCI 5 mg), 8 FL OZ (237 mL) bottles, Distributed by: Walgreen Co, Deerfield, IL 60015 ----  NDC 0363-0229-08", "report_date": "20130313", "classification": "Class III", "openfda": {}, "recalling_firm": "Aaron Industries Inc", "recall_number": "D-185-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64298", "termination_date": "20131101", "recall_initiation_date": "20130118", "postal_code": "90262-4022", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Horsham", "address_1": "2 Walnut Grove Dr", "reason_for_recall": "Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.", "address_2": "Suite 190", "product_quantity": "1,176 bottles", "code_info": "Lot 238316, exp 01/31/2014", "center_classification_date": "20130227", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "PA", "product_description": "Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09", "report_date": "20130306", "classification": "Class II", "openfda": {}, "recalling_firm": "Amedra Pharmaceuticals LLC", "recall_number": "D-171-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63926", "termination_date": "20140321", "recall_initiation_date": "20121204", "postal_code": "19044-2219", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077302"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0228-3059", "0228-3062", "0228-3063", "0228-3060", "0228-3064", "0228-3061"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "spl_id": ["add9fb1a-a8f3-4159-84f9-9335e8c963bb"], "spl_set_id": ["c5c2d060-452c-4f76-ad93-2e41fd8f06c2"], "package_ndc": ["0228-3062-11", "0228-3059-11", "0228-3063-11", "0228-3060-11", "0228-3064-11", "0228-3061-11"], "is_original_packager": [true], "upc": ["0302283059110", "0302283064114", "0302283063117"], "unii": ["JJ768O327N", "O1ZPV620O4", "6DPV8NK46S", "G83415V073"]}, "product_type": "Drugs", "event_id": "64506", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "N/A", "postal_code": "07207", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-190-2013", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules, 15 mg, Rx Only, C II, 100 capsules per bottle, MFG. By Actavis Elizabeth LLC. 200 Elmora Ave, Elizabeth, NJ, 07207, USA, NDC 0228-3063-11.", "product_quantity": "9,264 Bottles", "reason_for_recall": "Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications.  All other test specifications were met.", "recall_initiation_date": "20130213", "center_classification_date": "20130307", "termination_date": "20140306", "report_date": "20130313", "code_info": "Lot #: 50077231"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63285", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-179-2013", "product_description": "Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli,  India 502 325, NDC 55111-343-30", "product_quantity": "86, 093 bottles", "reason_for_recall": "Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.", "recall_initiation_date": "20120801", "center_classification_date": "20130228", "termination_date": "20130524", "report_date": "20130306", "code_info": "Lot #: C201922, Exp 1/14"}, {"status": "Terminated", "city": "Gainesville", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64223", "recalling_firm": "Stat Rx USA", "address_1": "2481 Hilton Dr", "address_2": "N/A", "postal_code": "30501-6213", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "PA", "recall_number": "D-144-2013", "product_description": "Methocarbamol 750 mg Tablets, 90-count bottle, Mfg by: West-Ward Pharm. Corp., Eatontown, NJ 07724, Packaged and Distributed by: Stat Rx USA, NDC 42549-521-90.", "product_quantity": "3 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. The product was mistakenly labeled with an expiration date of 10/16 instead of 01/16.", "recall_initiation_date": "20130128", "center_classification_date": "20130204", "termination_date": "20130606", "report_date": "20130213", "code_info": "A02568, Exp 01/16", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64198", "recalling_firm": "Pacira Pharmaceuticals, Inc.", "address_1": "10450 Science Center Dr", "address_2": "N/A", "postal_code": "92121-1119", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.", "recall_number": "D-168-2013", "product_description": "EXPAREL (bupivacaine liposome injectable suspension),  1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA", "product_quantity": "324 vials", "reason_for_recall": "Subpotent; bupivacaine", "recall_initiation_date": "20121217", "center_classification_date": "20130225", "termination_date": "20130503", "report_date": "20130306", "code_info": "Lot #11-2005  Control #23542  Manufacture Date: 05Dec11  2011-L-009"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-108-2013", "product_description": "Methylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "23,897 vials", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All Lot codes"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63821", "recalling_firm": "Bayer Healthcare, LLC", "address_1": "36 Columbia Rd", "address_2": "N/A", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-177-2013", "product_description": "Bronkaid Dual Action Formula, Ephedrine Sulfate 25 mg/Bronchodilator, Guaifenesin 400 mg/Expectorant, a) 24 coated caplets per blister pack, UPC 300240537879, b) 60 coated caplets per blister pack,  UPC 300240537855, Bayer HealthCare LLC, Consumer Care, P.O. Box 1910, Morristown, NJ, 07962.", "product_quantity": "1,353,420 Blister Packs", "reason_for_recall": "Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label.", "recall_initiation_date": "20121207", "center_classification_date": "20130228", "termination_date": "20140401", "report_date": "20130306", "code_info": "Lot #s: a) NAA0B3T, NAA0BDB, NAA0B3P, NAA0B3R, NAA0B3N, NAA070E, NAA070F, NAA03PX, NAA03B5, NAA03B6, NAA02LT.    b) NAA0TF3, NAA0TF2, NAA0TF0, NAA0TF1, NAA0TET, NAA0TEW, NAA0TEX, NAA0HHL, NAA0HHK, NAA0HHN, NAA0HHH, NAA0DK5, NAA0DK4, NAA0DK3, NAA0CHE, NAA0CHD, NAA0B3L, NAA0B3K, NAA09XE, NAA09XB, NAA07H2, NAA09XD, NAA07H1, NAA09XA, NAA09XC, NAA07H3, NAA07H4, NAA05BB, NAA05BA, NAA07H0, NAA070D, NAA070C, NAA03PW, NAA05B9, NAA070B, NAA03B8, NAA03B7, NAA02N1, NAA02LW, 244511P, 244501P, 244481P, 244471P, 244491P, 244451P."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64441", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-176-2013", "product_description": "0.9% Sodium Chloride Irrigation, USP, 3000 mL, Sterile, Non pyrogenic, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7972-08", "product_quantity": "56,854 Units", "reason_for_recall": "Lack of Assurance of Sterility: There is a potential for the solution to leak from the administration port of the primary container.", "recall_initiation_date": "20130212", "center_classification_date": "20130228", "termination_date": "20150424", "report_date": "20130306", "code_info": "Lot 13-121-JT*    * the lot number may be followed by 01"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63967", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-132-2013", "product_description": "Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.", "product_quantity": "43,478 bottles", "reason_for_recall": "Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.", "recall_initiation_date": "20121130", "center_classification_date": "20130118", "termination_date": "20140709", "report_date": "20130130", "code_info": "Lot #: 69392A,  69393A, 69394A, 69395A, 69396A, 69397A , Exp 09/15; 69495A, 69496A, 69497A, 69498A, 69524A, 69525A, Exp 10/15"}, {"country": "United States", "city": "Maple Grove", "address_1": "6701 Evenstad Drive", "reason_for_recall": "Failed Dissolution Test Requirements", "address_2": "", "product_quantity": "60 bottles", "code_info": "Lot #308198, Expiration Date is 03/2014", "center_classification_date": "20130208", "distribution_pattern": "FL, NJ.", "state": "MN", "product_description": "Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447  ---  NDC 0245-0085-11, UPC 3 0245-0085-11 9", "report_date": "20130220", "classification": "Class II", "openfda": {}, "recalling_firm": "Upsher Smith Laboratories, Inc.", "recall_number": "D-160-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "63908", "termination_date": "20130712", "more_code_info": "", "recall_initiation_date": "20121120", "postal_code": "55369", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63969", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-149-2013", "product_description": "PredniSONE Tablets, USP, 10 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1473-01), b) 1000-count tablets per bottle (NDC 0143-1473-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.", "product_quantity": "128,319 bottles", "reason_for_recall": "Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.", "recall_initiation_date": "20121205", "center_classification_date": "20130205", "termination_date": "20150318", "report_date": "20130213", "code_info": "Lot #: 69403A,  69403B, Exp 10/15; 69404A, 69405A, 69515A, 69702A, 69702B, 69703A, Exp 11/15; 69767A, 69767B, Exp 12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64317", "recalling_firm": "Actavis Pharmaceuticals", "address_1": "60 Columbia Rd Bldg B", "address_2": "N/A", "postal_code": "07960-4535", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-175-2013", "product_description": "buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217", "product_quantity": "14,856 bottles", "reason_for_recall": "Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.", "recall_initiation_date": "20130104", "center_classification_date": "20130227", "termination_date": "20140113", "report_date": "20130306", "code_info": "Lot CB1D05A,"}, {"status": "Terminated", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64416", "recalling_firm": "Humco Holding Group, Inc", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-197-2013", "product_description": "Mercuroclear Antiseptic Anesthetic First Aid Helps prevent infection and relieves pain and itching of minor cuts, scrapes, burns and insect bites.  Active Ingredients Benzalkonium chloride 0.13% - First Aid antiseptic, Lidocaine hydrochloride 2.5% - External analgesic,  Sold under the following brands:  a) Good Neighbor Pharmacy, NDC 24385-593-46; b) Quality Choice, NDC 63868-0488-02; c) Select Brand NDC 15127-885-59; d) Premier Value; e) CVS Pharmacy; f) Rite Aid Pharmacy; g) Top Care; h) HEB; and i) Humco.", "product_quantity": "1,269,846 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Product(s): The product has the potential to be contaminated with Bulkholderia gladioli.", "recall_initiation_date": "20130117", "center_classification_date": "20130312", "termination_date": "20170126", "report_date": "20130320", "code_info": "a) Good Neighbor, Item Number 163792006:  Lot #s: 534204, 538468, 540540; b)  Quality Choice, Item Number 163792066:  Lot #s: 538835, 539431; c) Select Brands, Item Number 163792067:  Lot #: 540529; d) Premier Value, Item Number 163792079: Lot #s: 534545 and 535307; e) CVS, Item Number 163791091 (1 oz.):  Lot #s 533472, 534055, 534256, 534546, 534995, 535249, 535318, 535683, 536302, 537285, 538138, 538189, 538439, 538672; and Item Number 163792091 (2 oz.): Lot #s: 538408, 540530, 540542, 540712; f) Rite Aid, Item Number 163792088: Lot #s: 533471, 534067, 534337, 534548, 535512, 535876, 536526, 537076, 537284, 538229, 538469, 538864, 539475, 540714, 541285, 541304, 541415, 541672; g) Top Care, Item Number 163792101:  Lot #: 535070, 535681, 537323, 537376, and 537587; h) H.E.B, Item Number 163793800: Lot #s: 534442, 534701, 534981, 535332, 535403, 536300; and i) HUMCO, Item Number 163792001, 163792015 (2 oz.): Lot #s 534612, 534767, 535402, 535845, 536899, 537335, 537586, 538219, 538470, 538865, 539691, 539803, 539845, 541193 and 533470, 533554, 534032, 534057, 534158, 534399, 534547, 534686, 535069, 535246, 535317, 535682, 535874, 536247, 536301, 536900, 537075, 537283, 537588, 537722, 537960, 538190, 538191, 538289, 538410, 538671, 538673, 539640, 539692, 540143, 540144, 540176, 540539, 540713, 540820, 540851, 541101, 541146, 541195, 541611, 541673; and Item Number 163793001 (3 oz.): Lot #s: 534165, 534748, 535404, 537751, 539387, 540029, 540296, 540711.", "more_code_info": ""}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-115-2013", "product_description": "Clonidine 100 mcg/mL PF, 1mL and 2 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "2747 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62664", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distribution was nationwide and to Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-102-2013", "product_description": "Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA", "product_quantity": "1,924,133/75-mcg. tablets", "reason_for_recall": "Subpotent; 9-month stability interval", "recall_initiation_date": "20120725", "center_classification_date": "20121221", "termination_date": "20131114", "report_date": "20130102", "code_info": "Lot HF23111"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64533", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Panama", "recall_number": "D-210-2013", "product_description": "4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2087-05) b) 1-fl. oz. bottles (NDC 0067-2087-01), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.", "product_quantity": "44,604/ .5-fl. oz. bottles and 439,452 /1-fl. oz. bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.", "recall_initiation_date": "20130307", "center_classification_date": "20130321", "termination_date": "20141126", "report_date": "20130327", "code_info": "Lot #: a) 10120598, Exp 7/13; 10127563, Exp 11/13; b) 10107920, 10108362, 10108363, 10108364, 10109881, 10110017, 10110018, 10110019, 10110020, 10120730, 10120731, 10120732, 10120733, 10120734, 10120735, 10120736, 10127556, 10127557, 10127558, and 10127559, Exp 3/13 to 10/13."}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M012"], "brand_name": ["4 WAY"], "generic_name": ["PHENYLEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0067-2086"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1087043"], "spl_id": ["43684c76-26b5-24c9-e063-6294a90a9b46"], "spl_set_id": ["a8fc41c7-4425-41b8-b1c6-eb22ac054734"], "package_ndc": ["0067-2086-01", "0067-2086-05", "0067-2086-15"], "is_original_packager": [true], "unii": ["04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "64533", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Panama", "recall_number": "D-209-2013", "product_description": "4 way Nasal Decongestant Fast Acting Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2086-05), b) 1-fl. oz. bottles (NDC 0067-2086-01), c) 1.25-fl. oz. bottles (NDC 0067-2086-15), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.", "product_quantity": "538,092/.5-fl. oz. bottles,  1,186,740/1-oz. bottles, and  138,528/1.25-fl. oz bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.", "recall_initiation_date": "20130307", "center_classification_date": "20130321", "termination_date": "20141126", "report_date": "20130327", "code_info": "Lot #: a) 10108375, 10108376, 10110025, 10110026, 10115487, 10115488, 10120594, 10120595, 10120596, 10120597, 10120753, 10120754, 10120755, 10127564, and 10127567, Exp 4/13 to 11/13, b) 10107916, 10108368, 10108369, 10108370, 10108371, 10108372, 10108373, 10108374, 10110027, 10110028, 10110029, 10110030, 10110031, 10110032, 10110033, 10115803, 10115804, 10115805, 10115806, 10115807, 10115809, 10115810, 10115812, 10115813, 10115814, 10115815, 10120728, 10120737, 10120738, 10120739, 10120740, 10120741, 10120742, 10120743, 10120744, 10120745, 10120746, 10120747, 10120748, 10120749, 10120750, 10120751, 10120752, 10121325, 10127542, 10127543, 10127544, 10127545, 10127546, 10127547, 10127548, 10127549, 10127550, Exp 3/13 to 10/13, c) 10116175, 10117996, 10117997, 10117998, 10117999, 10127535, 10127536, 10127537, 10127538, 10127539, 10127540, and 10127541, Exp 9/13 to 10/13."}, {"status": "Terminated", "city": "Westborough", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020929"], "brand_name": ["PULMICORT RESPULES"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0186-1988", "0186-1989", "0186-1990"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["BUDESONIDE"], "rxcui": ["252559", "349094", "351109", "616817", "616819", "616830"], "spl_id": ["76a8044c-b6f4-4da4-b855-a281fdca66b4"], "spl_set_id": ["33cd9834-76df-4f26-3fa2-aab6b9eee8f2"], "package_ndc": ["0186-1988-04", "0186-1989-04", "0186-1990-04"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "64041", "recalling_firm": "AstraZeneca LP", "address_1": "50 Otis Street", "address_2": "N/A", "postal_code": "01581-4500", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-198-2013", "product_description": "PULMICORT RESPULES 0.25 mg/2 ml   Budesonide Inhalation Suspension  (30 ampules/carton)  NDC: 0186-1988-04", "product_quantity": "28,476 cartons", "reason_for_recall": "Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.", "recall_initiation_date": "20130111", "center_classification_date": "20130312", "termination_date": "20130726", "report_date": "20130320", "code_info": "Lot/Exp date:  AH0054 Exp 5/14; AK0125 Exp 7/14", "more_code_info": ""}, {"status": "Terminated", "city": "Iowa City", "state": "IA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64137", "recalling_firm": "Procter & Gamble Hair Care Llc", "address_1": "2200 Lower Muscatine Rd", "address_2": "N/A", "postal_code": "52240-2302", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-167-2013", "product_description": "Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral Rinse, 250 mL (8.4 fl oz),Dist.  by Procter & Gamble, Cincinnati, OH 45202  NDC 37000-452-02", "product_quantity": "71,040 bottles", "reason_for_recall": "Cross Contamination with Other Products: Product was mixed with another type of mouth wash.", "recall_initiation_date": "20130123", "center_classification_date": "20130219", "termination_date": "20140603", "report_date": "20130227", "code_info": "22155395UA  Expires: 07/2014"}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-120-2013", "product_description": "Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64312", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-204-2013", "product_description": "Meprobamate; Tablets USP, 400 mg, 100 tablets; Rx only;  Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 0591-5238-01", "product_quantity": "20,587 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate  because an out of specification result for an impurity diphenyl sulfone .", "recall_initiation_date": "20130208", "center_classification_date": "20130319", "termination_date": "20140131", "report_date": "20130327", "code_info": "387879A, Exp. 02/13; 429105A, Exp. 06/13; 474488A, Exp. 11/13; 491672A, Exp. 01/14; 529095A, Exp. 04/14"}, {"status": "Terminated", "city": "Lincoln", "state": "NE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64533", "recalling_firm": "Novartis Consumer Health", "address_1": "10401 Hwy 6", "address_2": "N/A", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Panama", "recall_number": "D-207-2013", "product_description": "Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.", "product_quantity": "240,120/2-oz. tubes and  429,144/4-oz. tubes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.", "recall_initiation_date": "20130307", "center_classification_date": "20130321", "termination_date": "20141126", "report_date": "20130327", "code_info": "Lot #: a) 10086783, 10088745, 10088746, 10090537, 10093867, 10093868, 10098162, 10098541, 10098542, 10102311, 10109145, 10109146, 10120111, 10122759, and 10122760, Exp 3/13 to 9/14; b) 10086785, 10088747, 10088748, 10090538, 10093869, 10093870, 10098160, 10098161, 10098540, 10099841, 10104146, 10109143, 10109144, 10111501, 10115614, 10120112, 10121759, 10122698, 10122757, and 10122758, Exp 3/13 to 10/14."}, {"status": "Terminated", "city": "Framingham", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "63305", "recalling_firm": "New England Compounding Center", "address_1": "697 Waverly St", "address_2": "N/A", "postal_code": "01702-8589", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-111-2013", "product_description": "Methylprednisolone Acetate  80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA", "product_quantity": "3822 vials", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20120926", "center_classification_date": "20121231", "termination_date": "20161007", "report_date": "20130109", "code_info": "All lot codes"}]